Get the Stockscreener App
175.67
0.06%
0.11
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $175.67, with a volume of 2.11M.
It is up +0.06% in the last 24 hours and down -9.11% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$175.56
Open:
$176.42
24h Volume:
2.11M
Relative Volume:
1.09
Market Cap:
$78.47B
Revenue:
$9.15B
Net Income/Loss:
$2.43B
P/E Ratio:
35.71
EPS:
4.92
Net Cash Flow:
$2.31B
1W Performance:
-0.77%
1M Performance:
-9.11%
6M Performance:
+0.73%
1Y Performance:
-0.22%
1-Day Range:
$173.83
$177.41
1-Week Range:
$170.75
$178.97
52-Week Range:
$144.80
$201.92
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ZTS | 175.67 | 78.47B | 9.15B | 2.43B | 2.31B | 4.92 |
| HLN | 9.48 | 42.84B | 14.26B | 1.55B | 0 | 0.3327 |
| TAK | 13.29 | 42.13B | 30.27B | 1.93B | 3.45B | 0.444 |
| TEVA | 17.03 | 19.19B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.13 | 15.67B | 15.24B | -646.50M | 1.88B | 1.53 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis loses appeal over pig vaccine patents - Lawyerly
Zoetis Inc. (NYSE:ZTS) Shares Sold by Portfolio Design Labs LLC - MarketBeat
Companion Animal Arthritis Market Innovations in Treatment - openPR
Meeder Asset Management Inc. Sells 27,452 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pain Management Market Overall Study Report - openPR
Zoetis raises another $100K for mental health support in rural Australia - Sheep Central
High-Flying Genetics Testing Firm GeneDx Hires Ex-Zoetis GC as Legal Chief - Law.com
Sheep and Goats Healthcare Market May See Big Move | Zoetis ,Merck Animal Health - openPR
B. Metzler seel. Sohn & Co. Holding AG Acquires New Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
Is Zoetis Inc. (NYSE:ZTS) Trading At A 29% Discount? - Yahoo Finance
Cantillon Capital Management LLC Sells 38,425 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Quest Partners LLC Raises Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Poultry Vaccine Market Growth in Future Scope 2024-2031 | Zoetis Inc., Merck & Co. Inc., Elanco, Ceva Santé Animale - openPR
Pet Vaccine Market to Get a New Boost | Zoetis , Merck Animal Health - openPR
Empowered Funds LLC Has $3.31 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Point-of-Care Diagnostics Market 2024-2031 | - openPR
MAI Capital Management Sells 4,871 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy (NYSE:ZTS) - Seeking Alpha
Thrivent Financial for Lutherans Sells 95,529 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Sawgrass Asset Management LLC Sells 21,530 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
CIBC Asset Management Inc Raises Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Bought by Comgest Global Investors S.A.S. - MarketBeat
Mizuho Securities USA LLC Has $950.52 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Natixis Advisors LLC Acquires 32,407 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Impax Asset Management Group plc Trims Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Simplify Asset Management Inc. Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs - Town and Country TODAY
Dearborn Partners LLC Sells 3,748 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis debuts AI-powered haematology tech at London Vet Show - vet times
Victory Capital Management Inc. Grows Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
What Are Wall Street Analysts' Target Price for Zoetis Stock? - MSN
What Are Wall Street Analysts' Target Price For Zoetis Stock? - Barchart
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Huntington National Bank - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by KBC Group NV - MarketBeat
Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc - GuruFocus.com
Sumitomo Mitsui Trust Group Inc. Raises Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Announces Major Leadership Changes for Growth - TipRanks
Aigen Investment Management LP Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Ashton Thomas Private Wealth LLC Lowers Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Arthritis Foundation Zoetis Partnership Supports Patients and Pets - Arthritis Foundation
The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis - AccessWire
Zoetis Inc. (NYSE:ZTS) Stake Reduced by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Zoetis Names Jamie Brannan as First Chief Commercial Officer - Swineweb.com
Zoetis Inc. (NYSE:ZTS) Shares Purchased by Waverton Investment Management Ltd - MarketBeat
GSA Capital Partners LLP Buys Shares of 11,354 Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Bought by Nations Financial Group Inc. IA ADV - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Chartwell Investment Partners LLC - MarketBeat
WATCH: CO Dog mayor gives ‘paw of approval’ on opening day - AOL
Phibro Animal Health completes acquisition of Zoetis’ medicated feed additive portfolio - www.thecattlesite.com
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
2.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):